| |  |
CordenPharma is your full-service CDMO in the manufacturing of APIs, Excipients, Drug Products and Packaging Services. Through a network of facilities organized under five technology platforms - Peptides - Lipids & Carbohydrates - Injectables - Highly Potent & Oncology - Small Molecules - CordenPharma experts translate complex ideas into high-value products.Peptides - World-class development & manufacturing services seamlessly supporting all clinical & commercial stages
- Fully-integrated solution from drug substance to fill & finish drug product
- Unique expertise in both SPPS & LPPS technology for efficient Peptide manufacturing
- Full access to batch record process (you own the IP) and knowledge sharing guaranteed
- Largest equipment available to leverage sizeable up and downstream processes for your APIs
- Solvent recycling concepts with a green manufacturing approach
Lipids & Carbohydrates - Specialized Lipids offering including custom & standard lipids (Glycero-Phospholipids, Sphingolipids, Phosphocholine, Pegylated, and Cationic Lipids)
- Lipids for support of mRNA vaccine production including Phosphocholine, Pegylated, Cationic Lipids and highly pure plant-based CP BotaniChol® (cholesterol)
- Fully-integrated service offering > from APIs to finished dosage and pharmaceutical services (clinical trial kits preparation, randomization and logistics)
- Backward integration of key starting materials to secure supply chain
- Manufacturing of carbohydrate-based APIs, vaccines, delivery systems, and conjugates (with lipids and/or peptides for receptor targeting)
Sterile Injectables - Wide & balanced range of injectable services (including combining injectable drugs & devices as combination products)
- Aseptic & Terminal Sterilization Fill & Finish Technologies for Pre-Filled Syringes (PFS), ampoules, liquid and lyophilized vials, supporting a wide range of filling volumes
- Substantial Drug Product regulatory and filing experience globally (EMEA, FDA, PMDA)
- Packaging / labeling Clinical trial drug kit management (logistics, track & trace, documentation)
- LNP Formulation of Drug Products
Highly Potent & Oncology Small Molecules - Integrated network of cGMP facilities across Europe and US
- 1,200 m3 of volumetric capacity in 20 L - 28,000 L reactors with various materials of construction
- Clinical (Phase I-III) and ongoing commercial supply to multiple markets around the world (including US, Europe and Japan)
- Kilo to Multi-ton production volumes per annum
- Process development capabilities (including flow / continuous manufacturing
- All sites FDA & EMEA approved facilities with successful regulatory & customer audits
- Strong EHS programs in place at sites
|
Product List: 58
PON:Page:
|
| |
Phosphatidic Acids | DLPA, NA CAS:108321-06-8 LP-R4-121 | DMPA, NA CAS:80724-31-8 LP-R4- 024 | DPPA, NA CAS:169051-60-9 LP-R4- 025 | DSPA, NA CAS:108321-18-2 LP-R4- 026 | PHOSPHATIDIC ACIDS |
Phosphoglycerols | DLPG, NA CAS:73548-69-3 LP-R4- 079 | DMPG, NA CAS:200880-40-6 LP-R4- 015 | DPPG, NA CAS:200880-41-7 LP-R4- 016 | DSPG, NA CAS:124011-52-5 LP-R4- 017 | PHOSPHOGLYCEROLS |
Phosphoethanolamines | 1,3-DPPE CAS:67303-93-9 LP-R4-167 | DLPE CAS:42436-56-6 LP-R4- 064 | DMPE CAS:998-07-2 LP-R4- 018 | DOPE CAS:4004-05-1 LP-R4- 069 | DPPE CAS:923-61-5 LP-R4- 019 | DPYPE CAS:201036-16-0 LP-R4-147 | DSPE CAS:1069-79-0 LP-R4- 020 | PHOSPHOETHANOLAMINES | POPE CAS:26662-94-2 LP-R4-266 |
Phosphocholines | DLPC CAS:18194-25-7 LP-R4-101 | DMPC CAS:18194-24-6 LP-R4- 058 | DOPC CAS:4235-95-4 LP-R4- 070 | DPEPC, CHLORIDE CAS:328250-18-6 LP-R4- 095 | DPEPC, TRIFLATE CAS:474945-32-9 LP-R4-102 | DPPC CAS:63-89-8 LP-R4- 057 | DPPC (SHORT ROUTE) CAS:63-89-8 LP-R4-108 | DSPC CAS:816-94-4 LP-R4- 076 | PHOSPHOCHOLINES |
MPEGylated (Methoxypolyethyleneglycol-) Phospholipids | MPEG-2000 -DMPE CAS:384835-59-0 LP-R4-123 | MPEG-2000 -DPPE CAS:205494-72-0 LP-R4- 080 | MPEG-2000 -DSPE CAS:147867-65-0 LP-R4- 039 | MPEG-5000 -DMPE LP-R4- 077 | MPEG-5000 -DPPE CAS:205494-72-0 LP-R4- 075 | MPEG-5000 -DSPE CAS:147867-65-0 LP-R4- 092 | MPEG-750 -DSPE CAS:147867-65-0 LP-R4- 087 | MPEGYLATED (METHOXYPOLYETHYLENEGLYCOL-) PHOSPHOLIPIDS |
Phospholipids with Heterogeneous Fatty Acid Chains | 1,3-POPE CAS:884324-34-9 LP-R4-163 | CHOLESTEROL (PLANT ORIGIN) CAS:57-88-5 CH- 0355 | POPC CAS:26853-31-6 LP-R4- 031 | POPC (SHORT ROUTE) CAS:26853-31-6 LP-R4-107 | POPG, NA CAS:268550-95-4 LP-R4-124 | POPG, NA (SHORT ROUTE) CAS:268550-95-4 LP-R4- 073 | POPG, NH4 CAS:267228-70-6 LP-R4- 074 | SMPC CAS:20664-02-2 LP-R4-152 |
Cholesterol, Derivative of | BOTANICHOI CHOLESTEROL (PLANT ORIGIN) CAS:57-88-5 CH- 0355 | CHOLESTEROL, DERIVATIVE OF | SCS (HIGH PURITY >98%) CAS:2864-50-8 LP-R4- 091 |
2-Lyso-phospholipids | 2-LYSO-PHOSPHOLIPIDS | P-LYSO-PC CAS:17364-16-8 LP-R4- 078 | P-LYSO-PC (SHORT ROUTE) CAS:17364-16-8 LP-R4- 098 | S-LYSO-PC CAS:19420-57-6 LP-R4- 083 | S-LYSO-PC (SHORT ROUTE) CAS:19420-57-6 LP-R4-113 |
Cationics | C12-200 CAS:1220890-25-4 LP- 04- 425 | CATIONICS | DODMA CAS:104162-47-2 LP-R4-110 | DOTAP CL CAS:132172-61-3 LP-R4-117 |
Sphingomyelin | P-SM18 CAS:6254-89-3 LP-R4- 096 | SPHINGOMYELIN |
|
|
|